Dey A - Search Results

1

Updates on p53: modulation of p53 degradation as a therapeutic approach.

Dey A, Verma CS, Lane DP. Dey A, et al. Br J Cancer. 2008 Jan 15;98(1):4-8. doi: 10.1038/sj.bjc.6604098. Epub 2008 Jan 8. Br J Cancer. 2008. PMID: 18182973 Free PMC article. Review.

2

R-Roscovitine simultaneously targets both the p53 and NF-kappaB pathways and causes potentiation of apoptosis: implications in cancer therapy.

Dey A, Wong ET, Cheok CF, Tergaonkar V, Lane DP. Dey A, et al. Cell Death Differ. 2008 Feb;15(2):263-73. doi: 10.1038/sj.cdd.4402257. Epub 2007 Nov 2. Cell Death Differ. 2008. PMID: 17975552

3

Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: implications in lung cancer therapy.

Dey A, Wong ET, Bist P, Tergaonkar V, Lane DP. Dey A, et al. Cell Cycle. 2007 Sep 1;6(17):2178-85. doi: 10.4161/cc.6.17.4643. Epub 2007 Jun 27. Cell Cycle. 2007. PMID: 17786042

4

Cyclin-dependent kinase inhibitors sensitize tumor cells to nutlin-induced apoptosis: a potent drug combination.

Cheok CF, Dey A, Lane DP. Cheok CF, et al. Among authors: dey a. Mol Cancer Res. 2007 Nov;5(11):1133-45. doi: 10.1158/1541-7786.MCR-07-0161. Mol Cancer Res. 2007. PMID: 18025259

5

Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways.

Dey A, Tergaonkar V, Lane DP. Dey A, et al. Nat Rev Drug Discov. 2008 Dec;7(12):1031-40. doi: 10.1038/nrd2759. Nat Rev Drug Discov. 2008. PMID: 19043452 Review.

6

Modulating the p53 pathway.

Dey A, Lane DP, Verma CS. Dey A, et al. Semin Cancer Biol. 2010 Feb;20(1):3-9. doi: 10.1016/j.semcancer.2010.02.004. Epub 2010 Mar 1. Semin Cancer Biol. 2010. PMID: 20193765 Review.

7

HEXIM1 and the control of transcription elongation: from cancer and inflammation to AIDS and cardiac hypertrophy.

Dey A, Chao SH, Lane DP. Dey A, et al. Cell Cycle. 2007 Aug 1;6(15):1856-63. doi: 10.4161/cc.6.15.4556. Epub 2007 Jun 6. Cell Cycle. 2007. PMID: 17671421 Review.

8

Hexamethylene bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF kappaB activity: implications for cancer therapy.

Dey A, Wong E, Kua N, Teo HL, Tergaonkar V, Lane D. Dey A, et al. Cell Cycle. 2008 Dec;7(23):3759-67. doi: 10.4161/cc.7.23.7213. Epub 2008 Dec 10. Cell Cycle. 2008. PMID: 19029824

9

Ubiquitination of HEXIM1 by HDM2.

Lau J, Lew QJ, Diribarne G, Michels AA, Dey A, Bensaude O, Lane DP, Chao SH. Lau J, et al. Among authors: dey a. Cell Cycle. 2009 Jul 15;8(14):2247-54. doi: 10.4161/cc.8.14.9015. Cell Cycle. 2009. PMID: 19617712

10

Nucleophosmin interacts with HEXIM1 and regulates RNA polymerase II transcription.

Gurumurthy M, Tan CH, Ng R, Zeiger L, Lau J, Lee J, Dey A, Philp R, Li Q, Lim TM, Price DH, Lane DP, Chao SH. Gurumurthy M, et al. Among authors: dey a. J Mol Biol. 2008 Apr 25;378(2):302-17. doi: 10.1016/j.jmb.2008.02.055. Epub 2008 Mar 4. J Mol Biol. 2008. PMID: 18371977

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,088 results

Search Page